真人做爰48姿势视图片|少妇真人直播免费视频|日本真人做爰A片|真人裸体做爰视频|真人与拘做爰视频免费观看|真人与拘做受免费视频一

穿孔素1(PRF1)多克隆抗體

Polyclonal Antibody to Perforin 1 (PRF1)

FLH2; HPLH2; P1; PFP; Pore Forming Protein; Cytolysin; Lymphocyte pore-forming protein

  • 穿孔素1(PRF1)多克隆抗體 產(chǎn)品包裝(模擬)
  • 穿孔素1(PRF1)多克隆抗體 產(chǎn)品包裝(模擬)
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

該抗體是針對PRF1的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識別PRF1。

用法

Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。

贈品

相關(guān)產(chǎn)品

編號 適用物種:Mus musculus (Mouse,小鼠) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPB317Mu01 穿孔素1(PRF1)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB317Mu02 穿孔素1(PRF1)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APB317Mu01 穿孔素1(PRF1)活性蛋白 Cell?culture;?Activity?Assays.
APB317Mu02 穿孔素1(PRF1)活性蛋白 Cell?culture;?Activity?Assays.
PAB317Mu01 穿孔素1(PRF1)多克隆抗體 WB; IHC; ICC; IP.
PAB317Mu02 穿孔素1(PRF1)多克隆抗體 WB; IHC; ICC; IP.
LAB317Mu81 穿孔素1(PRF1)多克隆抗體(異硫氰酸熒光素標(biāo)記) WB; IHC; ICC; IF.
LAB317Mu71 穿孔素1(PRF1)多克隆抗體(生物素標(biāo)記) WB; IHC; ICC.
WEB317Mu 穿孔素1(PRF1)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,寬范圍) Enzyme-linked immunosorbent assay for Antigen Detection.
SEB317Mu 穿孔素1(PRF1)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB317Mu 穿孔素1(PRF1)等多因子檢測試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志 參考文獻(xiàn)
Diagnostic Microbiology and Infectious Disease Granzyme B as a diagnostic marker of tuberculosis in patients with and without HIV coinfection [Pubmed:26915636]
FASEB?JOURNAL The immunoregulatory effects of CD8 T-cell–derived perforin on diet-induced nonalcoholic steatohepatitis [Pubmed: 30951375]
Theranostics A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors [Pubmed: 31695790]
Mol Immunol CD317 mediates immunocytolysis resistance by RICH2/cytoskeleton-dependent membrane protection [Pubmed: 33223223]
INVESTIGATIONAL NEW DRUGS Dual-function chimeric antigen receptor T cells targeting c-Met and PD-1 exhibit potent anti-tumor efficacy in solid tumors [Pubmed: 32772342]
Am J Transl Res Combined treatment with epigenetic agents enhances anti-tumor activity of T cells by upregulating the ACRBP expression in hepatocellular carcinoma [34377237]
Nat Biomed Eng Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy [34873307]
J Exp Med Single-cell immune profiling reveals functional diversity of T cells in tuberculous pleural effusion [Pubmed:35061012]
留言咨詢
霍山县| 阿克| 新津县| 镇雄县| 剑川县| 潮州市| 宁安市| 连平县| 得荣县| 资溪县| 久治县| 鹤壁市| 义马市| 类乌齐县| 安西县| 兰坪| 肥东县| 禄劝| 观塘区| 金沙县| 阳东县| 新建县| 亳州市| 额敏县| 淳化县| 宁津县| 灵璧县| 房山区| 景洪市| 宝鸡市| 嘉兴市| 湟源县| 繁峙县| 邵阳市| 广西| 依兰县| 大英县| 华蓥市| 威远县| 彭山县| 永丰县|